Biohaven reports positive patient data for autoimmune disease drugs

Go back to Biohaven reports positive patient data for autoimmune disease drugs
(NYSE: BHVN) Delayed: 11.28 -0.09 (0.79%)
Previous Close $11.37    52 Week High
Open $11.43    52 Week Low
Day High $11.99    P/E N/A 
Day Low $11.26    EPS
Volume 2,361,335